Stericycle, Inc. Reports Third-Quarter 2017 Results

Loading...
Loading...

LAKE FOREST, Ill., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Stericycle, Inc. SRCL today reported results for the third quarter ended September 30, 2017.

THIRD-QUARTER HIGHLIGHTS COMPARED TO PRIOR YEAR:

  • Revenues of $882.8 million, a decrease of 0.8%, or an increase of 0.1% when excluding Manufacturing and Industrial
  • Gross profit of $368.0 million, a decrease of 2.1%
  • Earnings per share ("EPS") of $0.41, a decrease of 43.1%, and Adjusted earnings per share ("Adjusted EPS") of $1.10, a decrease of 11.3%
  • Company announces a comprehensive Business Transformation focused on driving operational efficiencies and investing in a global ERP system to improve long-term financial performance

THIRD-QUARTER RESULTS

"We saw strong performance across our Secure Information Destruction, hospital regulated waste, and retail and healthcare hazardous waste services in the quarter. The small quantity healthcare and Communication and Related Services results were consistent with our expectations," said Charles A. Alutto, President and Chief Executive Officer. "Also in the quarter, Manufacturing and Industrial came in lower than anticipated, we experienced cost pressure in Latin America, and we were impacted by several hurricanes." 

Revenues were $882.8 million in the third quarter of 2017, a decrease of 0.8% from $890.1 million in the third quarter of last year. Acquisitions contributed $6.8 million to revenues. Divestitures reduced revenues by $9.9 million. On a constant currency basis, revenues decreased 0.9% compared to the third quarter of last year. Organic revenues decreased 0.6%, or increased 0.2% when adjusted for Manufacturing and Industrial Services. See Tables 1-A and 1-C.

Gross profit was $368.0 million, a decrease of 2.1% from $376.0 million in the third quarter of last year. Adjusted gross profit was $368.0 million, a decrease of 2.6% from $377.7 million in the third quarter of last year. Gross profit and Adjusted gross profit as a percentage of revenues were both 41.7% compared to 42.2% and 42.4%, respectively, in the third quarter of last year. See Table 2.

EPS decreased 43.1% to $0.41 from $0.72 in the third quarter of last year. Adjusted EPS decreased 11.3% to $1.10 from $1.24 in the third quarter of last year. See Tables 3 and 4.

"During the third quarter, we initiated a comprehensive multi-year Business Transformation initiative to improve our long-term operational and financial performance. This Transformation will optimize the organization and modernize our systems and processes," Alutto said. "The Business Transformation will include the implementation of an enterprise resource planning technology platform, a restructuring of the organization, and multiple other improvement initiatives to reduce costs."

NINE-MONTH HIGHLIGHTS COMPARED TO PRIOR YEAR:

  • Revenues of $2.69 billion, an increase of 1.4%, or an increase of 2.6% when excluding Manufacturing and Industrial
  • Gross profit of $1.12 billion, a decrease of 0.2%
  • Loss per share of $0.70, a decrease of 136.3%, due primarily to the impact of the previously announced class action settlement ("Settlement") of $295.0 million, and Adjusted EPS of $3.33, a decrease of 5.7%

NINE-MONTH RESULTS

Revenues were $2.69 billion for the nine months ended September 30, 2017, an increase of 1.4% from $2.66 billion in the same period last year. Acquisitions contributed $25.4 million to revenues. Divestitures reduced revenues by $11.4 million. On a constant currency basis, revenues increased 2.2% compared to the first nine months of last year. Organic revenues increased 1.6%, or 2.6% when adjusted for Manufacturing and Industrial Services. See Tables 1-B and 1-C.

Gross profit and Adjusted gross profit were both $1.12 billion for the nine months ended September 30, 2017 and 2016. Gross profit and Adjusted gross profit as a percentage of revenues were both 41.5% for the nine months ended September 30, 2017 compared to 42.2% and 42.3%, respectively, for the nine months ended September 30, 2016. See Table 2.

Loss per share decreased 136.3% to $0.70 for the nine months ended September 30, 2017, due primarily to the impact of the Settlement, from an EPS of $1.93 in the same period last year. Adjusted EPS decreased 5.7% to $3.33 from $3.53. See Tables 3 and 4.

Cash flow from operations for the nine months ended September 30, 2017 was $392.0 million, a decrease of 6.2% from $417.8 million in the same period last year.

CONFERENCE CALL INFORMATION

Conference call to be held November 8, 2017, 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available for 30 days by dialing 855-859-2056 or 404-537-3406, access code 92842471. To hear a live simulcast of the call or access the audio archive, visit the investor relations page on www.stericycle.com.

PRESENTATION AND DISCUSSION OF NON-GAAP INFORMATION

The Company reports its financial results in compliance with U.S. Generally Accepted Accounting Principles ("GAAP") and provides certain supplemental Non-GAAP financial measures that management uses to operate the Company's business. These Non-GAAP measures provide investors and analysts the ability to compare the Company's performance across reporting periods on a consistent basis by removing the impact of certain items that, in management's view, do not reflect the Company's underlying operating performance. These Non-GAAP measures are also used to evaluate senior management and are a factor in determining their performance-based compensation.

Adjusted EPS, Adjusted net income attributable to Stericycle common shareholders, Adjusted gross profit, Adjusted gross profit as a percentage of revenues, Adjusted revenues, and Revenues on a constant currency basis are described in the Reconciliation of Certain Non-GAAP Measures section of this document.

We present our change in revenues separately to show the impact of foreign currency, acquisitions, and divestitures because we believe that exclusion of these items better represents the Company's underlying business trends, including organic revenue changes. We also present revenues excluding Manufacturing and Industrial Services ("M&I") which allow for visibility to a revenue stream that has shown greater volatility than our other service lines.

For the purpose of evaluating operating performance, we present our financials to exclude the impact of certain acquisition-related items from our adjusted earnings. These adjustments include acquisition and integration expenses, intangible amortization expense, and the change in fair value of contingent consideration. This allows for comparison of period over period results without the impact of acquisition-related items. Further, we exclude the impact of certain other items from our adjusted earnings to allow for period over period comparison of results without the impact of items that may not occur each year and, if so, are due to different factors. For the periods presented, these adjustments include litigation and professional services expenses, restructuring, plant conversion and other related expenses, and contract exit expenses, and asset impairment charges and loss on disposal of assets held for sale.

For the purpose of calculating the ultimate EPS impact of our mandatory convertible preferred stock, we show the impact by excluding the mandatory convertible preferred stock dividend and using the "if-converted" method of share dilution. This provides the reader insight to how our diluted share count will be affected after these preferred shares are converted to common shares.

These Non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial results, but should be read in conjunction with the unaudited condensed consolidated statements of income (loss) and other information presented herein. The Non-GAAP financial measures in the press release may differ from similar measures used by other companies. A reconciliation of each Non-GAAP financial measure to the most directly comparable GAAP measure is included in the accompanying tables.

RECONCILIATION OF CERTAIN NON-GAAP MEASURES

 

Table 1 – A: RECONCILIATION OF REVENUES TO ADJUSTED REVENUES – 
THREE MONTHS ENDED SEPTEMBER 30, 2017
 
  
  Three Months Ended September 30, 
  In millions  Percentage Change (%) 
Global Revenues by Service 2017  2016  Change  Organic Acquisitions,
Net of
Divestiture
 Foreign
Exchange
 Change 
Regulated Waste and Compliance Services $502.4  $520.4  $(18.0)  (1.9%) (1.6%) 0.0% (3.5%)
Secure Information Destruction Services  204.7   187.1   17.6   6.4% 2.4% 0.6% 9.4%
Communication and Related Services  89.0   87.5   1.6   (0.1%) 1.6% 0.4% 1.8%
Manufacturing and Industrial Services  86.6   95.2   (8.5)  (7.6%) (0.8%) (0.6%) (9.0%)
Total Revenues, as Reported  882.8   890.1   (7.4)  (0.6%) (0.3%) 0.1% (0.8%)
Less: Manufacturing and Industrial Services  (86.6)  (95.2)                 
Total Revenues, as Adjusted $796.1  $795.0  $1.2   0.2% (0.3%) 0.2% 0.1%
                          
Domestic and Canada revenues $708.2  $702.4  $5.8   (0.2%) 0.8% 0.2% 0.8%
International revenues  174.6   187.7   (13.1)  (2.2%) (4.6%) (0.3%) (7.0%)
Total Revenues $882.8  $890.1  $(7.4)  (0.6%) (0.3%) 0.1% (0.8%)
 

 

Table 1 – B: RECONCILIATION OF REVENUES TO ADJUSTED REVENUES – 
NINE MONTHS ENDED SEPTEMBER 30, 2017
 
  
  Nine Months Ended September 30, 
  In millions  Percentage Change (%) 
Global Revenues by Service 2017    2016  Change  Organic Acquisitions,
Net of
Divestiture
 Foreign
Exchange
 Change 
Regulated Waste and Compliance Services $1,525.9    $1,550.3  $(24.4)  (0.5%) (0.3%) (0.7%) (1.6%)
Secure Information Destruction Services  621.2     562.3   59.0   8.0% 3.1% (0.7%) 10.5%
Communication and Related Services  285.4     258.0   27.4   9.9% 1.4% (0.7%) 10.6%
Manufacturing and Industrial Services  260.4     285.4   (25.0)  (6.6%) (0.8%) (1.4%) (8.8%)
Total Revenues, as Reported  2,692.9     2,655.9   37.0   1.6% 0.5% (0.8%) 1.4%
Less: Manufacturing and Industrial Services  (260.4)    (285.4)                 
Total Revenues, as Adjusted $2,432.5    $2,370.5  $62.0   2.6% 0.7% (0.7%) 2.6%
                            
Domestic and Canada revenues $2,156.7    $2,085.3  $71.3   2.4% 1.0% 0.1% 3.4%
International revenues  536.2     570.6   (34.4)  (1.0%) (1.1%) (3.9%) (6.0%)
Total Revenues $2,692.9    $2,655.9  $37.0   1.6% 0.5% (0.8%) 1.4%
 

 

Table 1 – C: DISAGGREGATED REVENUES CHANGE
  
In millions 
 Three Months Ended
September 30, 2017
  Nine Months Ended
September 30, 2017
 
Organic$(5.4) $43.7 
Acquisitions 6.8   25.4 
Divestiture (9.9)  (11.4)
Foreign exchange 1.1   (20.7)
Total Change$(7.4) $37.0 
        

 

Table 2: RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT
  
In millions 
 Three Months Ended September 30,  Nine Months Ended September 30, 
 2017  2016  2017  2016 
    % of
Revenues
     % of
Revenues
     % of
Revenues
     % of
Revenues
 
Gross Profit, as Reported$368.0  41.7% $376.0  42.2% $1,118.5  41.5% $1,120.2  42.2%
Plant conversion and other related expenses, and contract exit expense -  0.0%  1.7  0.2%  -  0.0%  2.5  0.1%
Gross Profit, as Adjusted$368.0  41.7% $377.7  42.4% $1,118.5  41.5% $1,122.7  42.3%
                            

 

Table 3: RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO STERICYCLE COMMON SHAREHOLDERS TO ADJUSTED NET INCOME ATTRIBUTABLE TO STERICYCLE COMMON SHAREHOLDERS
  
In millions, except share and per share data 
 Three Months Ended September 30,  Nine Months Ended September 30, 
 2017  2016  2017  2016 
Net Income (Loss) Attributable to Stericycle Common Shareholders, as Reported$35.4  $61.5  $(59.9) $165.5 
Adjustments:               
Intangible amortization expense 29.9   33.1   88.5   102.3 
Acquisition and integration expenses 16.4   21.4   60.0   68.9 
Litigation and professional services expenses 16.5   1.5   324.5   5.4 
Restructuring, plant conversion and other related expenses, and contract exit expenses 4.0   10.6   11.6   24.5 
Insurance Proceeds -   (3.1)  -   (3.1)
Asset impairment charges and loss on disposal of assets held for sale 14.9   -   28.1   - 
Change in fair value of contingent consideration 0.5   0.6   0.9   (2.1)
Add back convertible preferred stock dividend 9.0   9.7   27.5   29.9 
Total Adjustments 91.2   73.8   541.1   225.8 
Tax effect of above adjustments (a) (27.1)  (22.5)  (178.6)  (69.4)
Net Income Attributable to Stericycle Common Shareholders, as Adjusted$99.5  $112.8  $302.6  $321.9 
Earnings (Loss) Per Share - Diluted, as Reported$0.41  $0.72  $(0.70) $1.93 
Earnings Per Share - Diluted, as Adjusted$1.10  $1.24  $3.33  $3.53 
Weighted average number of common shares outstanding - diluted, as Reported 85,621,184   85,570,529   85,278,783   85,689,525 
Weighted average number of common shares outstanding - diluted, as Adjusted 85,621,184   85,570,529   85,605,537   85,689,525 
Additional dilution under if-converted method 5,048,824   5,495,861   5,152,582   5,590,105 
Weighted average number of common shares outstanding under if-converted method - diluted, as Adjusted 90,670,008   91,066,390   90,758,119   91,279,630 
                
(a)  The tax effect of adjusting items in an interim period is calculated based on applying either the statutory tax rate for the jurisdictions in which the adjustment occurred or, by adjusting the tax effect to consider the impact of applying an annual effective tax rate on an interim basis.

 

Table 4: RECONCILIATION OF EARNINGS (LOSS) PER SHARE TO ADJUSTED EPS
  
 Three Months Ended September 30,  Nine Months Ended September 30, 
         Change          Change 
 2017  2016  $ %  2017  2016  $ % 
Earnings (Loss) per Share, as Reported$0.41  $0.72  $(0.31) (43.1%) $(0.70) $1.93  $(2.63) (136.3%)
Intangible amortization expense 0.23  $0.25          0.68   0.77        
Acquisition and integration expenses 0.13  $0.16          0.45   0.51        
Litigation and professional services expenses 0.12  $0.01          2.45   0.04        
Restructuring, plant conversion and other related expenses, and contract exit expenses 0.04  $0.10          0.10   0.21        
Insurance Proceeds -  $(0.04)         -   (0.03)       
Asset impairment charges and loss on disposal of assets held for sale 0.13  $-          0.24   -        
Change in fair value of contingent consideration 0.01  $0.01          0.01   (0.02)       
Add back convertible preferred stock dividend 0.10  $0.11          0.32   0.35        
Impact of all adjustments under if-converted method (0.07) $(0.08)         (0.22)  (0.23)       
Earnings Per Share - Diluted, as Adjusted$1.10  $1.24  $(0.14) (11.3%) $3.33  $3.53  $(0.20) (5.7%)
Weighted average number of common shares outstanding under if-converted method - diluted 90,670,008   91,066,390          90,758,119   91,279,630        
 

 

Table 5: RECONCILIATION OF CASH FLOW FROM OPERATING ACTIVITIES TO ADJUSTED CASH FLOW FROM OPERATING ACTIVITIES
  
 Three Months Ended September 30,  Nine Months Ended September 30, 
         Change          Change 
 2017  2016  $ %  2017  2016  $ % 
Net Cash Provided by Operating Activities, as Reported$153,123  $172,328  $(19,205) (11.1%) $392,043  $417,768  $(25,725) (6.2%)
Acquisition and integration expenses 10,744   13,483          38,444   44,050        
Litigation and professional services expenses 10,218   903          15,741   3,328        
Restructuring, plant conversion and other related expenses, and contract exit expenses 3,116   -          7,619   8,502        
Insurance Proceeds -   (3,079)         -   (3,079)       
Customer advance funding for product reimbursement (1,740)  816          7,826   (2,334)       
Net Cash Provided by Operating Activities, as Adjusted$175,461  $184,451  $(8,990) (4.9%) $461,673  $468,235  $(6,562) (1.4%)
 

For more information about Stericycle, please visit our website at www.stericycle.com.

  
STERICYCLE, INC. AND SUBSIDIARIES 
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS 
        
In thousands 
 September 30, 2017  December 31, 2016 
ASSETS       
Current Assets:       
Cash and cash equivalents$52,171  $44,189 
Accounts receivable, net 627,904   634,902 
Prepaid expenses 53,783   46,214 
Other current assets 35,292   39,179 
Assets held for sale 25,556   9,134 
Total Current Assets 794,706   773,618 
Property, plant and equipment, net 729,571   723,894 
Goodwill 3,638,574   3,591,020 
Intangible assets, net 1,818,078   1,861,973 
Other assets 35,433   29,556 
Total Assets$7,016,362  $6,980,061 
        
LIABILITIES AND EQUITY       
Current Liabilities:       
Current portion of long-term debt$122,189  $72,822 
Bank overdrafts 22,582   4,391 
Accounts payable 144,600   152,881 
Accrued liabilities 593,202   228,526 
Deferred revenues 19,071   17,902 
Other current liabilities 65,420   63,473 
Liabilities held for sale 5,603   2,858 
Total Current Liabilities 972,667   542,853 
        
Long-term debt, net 2,633,732   2,877,315 
Deferred income taxes 501,647   645,371 
Other liabilities 89,595   98,136 
Equity:       
Preferred stock 7   7 
Common stock 854   852 
Additional paid-in capital 1,147,082   1,166,457 
Retained earnings 1,946,133   2,006,064 
Accumulated other comprehensive loss (286,693)  (367,643)
Total Stericycle, Inc.'s Equity 2,807,383   2,805,737 
Noncontrolling interests 11,338   10,649 
Total Equity 2,818,721   2,816,386 
Total Liabilities and Equity$7,016,362  $6,980,061 
 

 

STERICYCLE, INC. AND SUBSIDIARIES 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) 
                            
In thousands, except share and per share data 
 Three Months Ended September 30,  Nine Months Ended September 30, 
 2017  2016  2017  2016 
 $ % of Revenues  $ % of Revenues  $ % of Revenues  $ % of Revenues 
Revenues$882,774  100.0% $890,144  100.0% $2,692,906  100.0% $2,655,946  100.0%
Cost of revenues ("COR") exclusive of depreciation 491,062  55.6%  489,923  55.0%  1,505,169  55.9%  1,462,624  55.1%
Depreciation 23,673  2.7%  24,265  2.7%  69,284  2.6%  73,145  2.8%
Total cost of revenues 514,735  58.3%  514,188  57.8%  1,574,453  58.5%  1,535,769  57.8%
                            
Gross Profit, as Reported 368,039  41.7%  375,956  42.2%  1,118,453  41.5%  1,120,177  42.2%
Gross Profit, as Adjusted 368,039  41.7%  377,678  42.4%  1,118,453  41.5%  1,122,652  42.3%
                            
Selling, general and administrative expenses ("SG&A") exclusive of depreciation 267,720  30.3%  243,476  27.4%  1,083,281  40.2%  734,095  27.6%
Depreciation 6,716  0.8%  7,963  0.9%  19,374  0.7%  20,934  0.8%
Total SG&A expense, as Reported 274,436  31.1%  251,439  28.2%  1,102,655  40.9%  755,029  28.4%
Total SG&A expense, as Adjusted 192,176  21.8%  185,965  20.9%  589,120  21.9%  558,484  21.0%
                            
Income from Operations, as Reported 93,603  10.6%  124,517  14.0%  15,798  0.6%  365,148  13.7%
Income from Operations, as Adjusted Exclusive of Items Shown Below 175,863  19.9%  191,713  21.5%  529,333  19.7%  564,168  21.2%
                            
Adjusted Items:                           
Plant conversion and other related expenses, and contract exit expenses (COR) -     1,722  0.2%  -     2,475  0.1%
Intangible amortization expense (SG&A) 29,905  3.4%  33,128  3.7%  88,475  3.3%  102,311  3.9%
Acquisition and integration expenses (SG&A) 16,435  1.9%  21,427  2.4%  59,993  2.2%  68,870  2.6%
Litigation and professional services expenses (SG&A) 16,481  1.9%  1,481  0.2%  324,531  12.1%  5,445  0.2%
Restructuring, plant conversion and other related expenses, and contract exit expenses (SG&A) 4,049  0.5%  8,875  1.0%  11,568  0.4%  22,000  0.8%
Asset impairment charges and loss on disposal of assets held for sale (SG&A) 14,898  1.7%  4  0.0%  28,075  1.0%  4  0.0%
Change in fair value of contingent consideration (SG&A) 492  0.1%  559  0.1%  893  0.0%  (2,085) (0.1%)
Total Adjustments 82,260  9.3%  67,196  7.5%  513,535  19.1%  199,020  7.5%
                            
Other Expense:                           
Interest expense, net (24,482) (2.8%)  (24,690) (2.8%)  (71,526) (2.7%)  (73,089) (2.8%)
Other (expense) income, net (2,272) (0.3%)  2,932  0.3%  (5,423) (0.2%)  (437) (0.0%)
Total Other Expense (26,754) (3.0%)  (21,758) (2.4%)  (76,949) (2.9%)  (73,526) (2.8%)
                            
Income (Loss) Before Income Taxes 66,849  7.6%  102,759  11.5%  (61,151) (2.3%)  291,622  11.0%
                            
Income tax expense (benefit) 27,780  3.1%  37,586  4.2%  (14,585) (0.5%)  102,624  3.9%
                            
Net Income (Loss) 39,069  4.4%  65,173  7.3%  (46,566) (1.7%)  188,998  7.1%
                            
Less: net income attributable to noncontrolling interests 31  0.0%  378  0.0%  249  0.0%  1,383  0.1%
                            
Net Income (Loss) Attributable to Stericycle, Inc.$39,038  4.4% $64,795  7.3% $(46,815) (1.7%) $187,615  7.1%
                            
Mandatory convertible preferred stock dividend 8,957  1.0%  9,726  1.1%  27,506  1.0%  29,853  1.1%
Gain on repurchase of preferred stock (5,368) (0.6%)  (6,467) (0.7%)  (14,390) (0.5%)  (7,747) (0.3%)
                            
Net Income (Loss) Attributable to Stericycle, Inc. Common Shareholders$35,449  4.0% $61,536  6.9% $(59,931) (2.2%) $165,509  6.2%
                            
Earnings (Loss) Per Share - Diluted$0.41     $0.72     $(0.70)    $1.93    
                            
Weighted Average Number of Common Shares Outstanding - Diluted 85,621,184      85,570,529      85,278,783      85,689,525    
 

 

STERICYCLE, INC. AND SUBSIDIARIES 
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
        
In thousands 
 Nine Months Ended September 30, 
 2017  2016 
Operating Activities:       
Net (loss) income$(46,566) $188,998 
Adjustments to reconcile net (loss) income to net cash provided by operating activities:       
Stock-based compensation expense 17,262   16,671 
Depreciation 88,658   94,079 
Intangible amortization 88,475   102,311 
Deferred income taxes (156,191)  20,579 
Asset impairment charges and loss on disposal of assets held for sale 28,075   4 
Other, net 1,208   977 
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:       
Accounts receivable 17,112   (26,825)
Prepaid expenses (6,691)  (5,251)
Accounts payable (7,900)  681 
Accrued liabilities 364,082   6,141 
Other assets and liabilities 4,519   19,403 
Net Cash Provided by Operating Activities 392,043   417,768 
        
Investing Activities:       
Capital expenditures (91,730)  (100,981)
Payments for acquisitions, net of cash acquired (23,812)  (51,197)
Proceeds from sale of property and equipment 607   1,316 
Proceeds from sale of business 1,170   - 
Proceeds from insurance settlement -   2,358 
Other (2)  7 
Net Cash Used in Investing Activities (113,767)  (148,497)
        
Financing Activities:       
Repayments of long-term debt and other obligations (46,391)  (52,462)
Proceeds from foreign bank debt 2,542   68,711 
Repayments of foreign bank debt (19,013)  (68,211)
Repayments of term loan (100,000)  (250,000)
Proceeds from senior credit facility 1,269,329   1,205,270 
Repayments of senior credit facility (1,336,503)  (1,118,831)
Proceeds from bank overdrafts, net 18,190   - 
Payments of capital lease obligations (2,691)  (4,644)
Payments of deferred financing costs (2,712)  (605)
Payments for repurchase of common stock -   (40,814)
Proceeds from issuances of common stock 4,997   35,727 
Payments for repurchase of mandatory convertible preferred stock (30,832)  (24,263)
Dividends paid on mandatory convertible preferred stock (27,506)  (29,853)
Payments to noncontrolling interests (709)  (6,961)
Net Cash Used in Financing Activities (271,299)  (286,936)
Effect of exchange rate changes on cash and cash equivalents 1,005   2,322 
Net change in cash and cash equivalents 7,982   (15,343)
Cash and cash equivalents at beginning of period 44,189   55,634 
        
Cash and Cash Equivalents at End of Period$52,171  $40,291 
        
Non-Cash Activities:       
Net issuances of obligations for acquisitions$7,849  $31,394 
 
Loading...
Loading...

Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic and market conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of the collection, transportation, treatment and disposal of regulated waste or the proper handling and protection of personal and confidential information, the ability to obtain final court approval of the Settlement, the ultimate terms and conditions of the Settlement, the number of members of the Settlement class that may elect to opt out of the Settlement, the impact of the Settlement in future periods on the Company's consolidated financial statements, increases in transportation and other operating costs, the level of governmental enforcement of regulations governing regulated waste collection and treatment or the proper handling and protection of personal and confidential information, our obligations to service our substantial indebtedness and to comply with the covenants and restrictions contained in our private placement notes, term loan credit facility and revolving credit facility, our ability to negotiate additional financing arrangements on acceptable terms, our ability to execute on our Business Transformation initiatives and achieve the anticipated benefits and cost savings, our ability to execute our acquisition strategy and to integrate acquired businesses, competition and demand for services in the regulated waste and secure information destruction industries, political, economic and currency risks related to our foreign operations, impairments of goodwill or other indefinite-lived intangibles, variability in the demand for services we provide on a project or non-recurring basis, exposure to environmental liabilities, fluctuations in the price we receive for the sale of paper, the outcome of pending or future litigation, disruptions in or attacks on our information technology systems, compliance with existing and future legal and regulatory requirements, as well as other factors described in our filings with the U.S. Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.

FOR FURTHER INFORMATION CONTACT:

Investor Relations 847-607-2012

Loading...
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...